The Coen brothers didn't so much as provide the drama of a coin toss before slaughtering the competition last night, as their adaptation of Cormac McCarthy's No Country For Old Men took home four Oscars (including three for the Coens--best picture, best director, best adapted screenplay). Here are a few things you may have missed while being otherwise preoccupied by a psychopath with a cattlegun and a bad haircut:
- In a deal valued at up to $1.5 billion, Irish biopharmaco Elan may be spinning off its drug delivery technology unit, according to the Sunday Times (via Reuters).
- Theravance said on Saturday that FDA's planned advisory committee review of its antibiotic televancin was canceled. The meeting, scheduled for Wednesday, was to discuss Theravance's NDA for televancin in complicated skin and soft tissue infections; televancin was deemed 'approvable' by the agency last October. No word yet on the reason for the cancelation.
- The New York Times profiles the evolving science of schizophrenia treatment, focusing on Eli Lilly's development of the glutamate-modulating drug candidate LY2140023, led early on by neuroscientist Darryle Schoepp (who has since moved to Merck).
- The Boston Globe reveals the latest FDA insight: all employees must wash hands. Yes with soap!
No comments:
Post a Comment